Marco Onofrj Selected Research

Olanzapine (Zyprexa)

3/2016	Olanzapine-related repetitive focal seizures with lingual dystonia.
1/2011	Olanzapine enhances anxiety response to an SSRI in a woman with bipolar disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Onofrj Research Topics

Disease

28	Parkinson Disease (Parkinson's Disease) 11/2022 - 03/2003
19	Multiple Sclerosis 11/2023 - 01/2010
15	Dementia (Dementias) 01/2023 - 09/2003
13	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 07/2002
11	Relapsing-Remitting Multiple Sclerosis 12/2023 - 01/2019
8	Parkinsonian Disorders (Parkinsonism) 08/2015 - 11/2003
6	Hallucinations (Hallucination) 01/2020 - 03/2003
5	Neuroinflammatory Diseases 01/2023 - 01/2019
4	Stroke (Strokes) 02/2024 - 11/2019
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 07/2011
4	Medically Unexplained Symptoms 11/2022 - 01/2019
4	Nervous System Diseases (Neurological Disorders) 11/2022 - 01/2010
4	Cognitive Dysfunction 02/2022 - 01/2015
4	Inflammation (Inflammations) 01/2021 - 11/2012
3	Psychotic Disorders (Schizoaffective Disorder) 12/2023 - 12/2007
3	COVID-19 05/2022 - 04/2021
3	Delirium 01/2022 - 04/2021
3	Dystonia (Limb Dystonia) 10/2016 - 10/2007
3	Seizures (Absence Seizure) 10/2016 - 01/2014
3	Hyperthermia 07/2015 - 12/2005
3	Gambling (Pathological Gambling) 01/2014 - 09/2010
3	Tremor (Tremors) 07/2013 - 08/2007
3	Dyskinesias (Dyskinesia) 03/2011 - 12/2009
2	Mental Disorders (Mental Disorder) 12/2023 - 10/2021
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2021
2	Sudden Unexpected Death in Epilepsy 01/2023 - 01/2022
2	Atrophy 01/2023 - 01/2016
2	Headache (Headaches) 05/2022 - 02/2022
2	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022 - 01/2019
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 03/2016
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 11/2011
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2021 - 01/2014
2	Epilepsy (Aura) 01/2021 - 06/2008
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 07/2011
2	Meningitis 01/2019 - 10/2016
2	Synucleinopathies 01/2019 - 07/2011
2	Polyneuropathies (Polyneuropathy) 05/2015 - 12/2009
2	Guillain-Barre Syndrome 05/2015 - 12/2009
2	Deglutition Disorders (Dysphagia) 02/2014 - 12/2009
2	Anhedonia 07/2013 - 08/2012
2	Major Depressive Disorder (Major Depressive Disorders) 01/2013 - 08/2012
2	Lewy Body Disease (Lewy Body Dementia) 11/2012 - 11/2003
2	Nausea 03/2011 - 05/2007
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2024
1	Shock 02/2024
1	Wounds and Injuries (Trauma) 02/2024
1	Chronic Progressive Multiple Sclerosis 11/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Temporal Lobe Epilepsy 07/2022
1	Pain (Aches) 05/2022

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2010
12	Levodopa (L Dopa)FDA LinkGeneric 02/2022 - 07/2003
6	Fingolimod Hydrochloride (FTY720)FDA Link 02/2023 - 01/2019
6	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2009
5	Natalizumab (Tysabri)FDA Link 02/2023 - 01/2021
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 11/2012
5	Antipsychotic Agents (Antipsychotics)IBA 10/2016 - 12/2005
4	Dimethyl FumarateIBA 02/2023 - 01/2019
4	AntibodiesIBA 01/2023 - 01/2021
4	Cholinergic Agents (Cholinergics)IBA 01/2022 - 07/2008
4	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 07/2008
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2008 - 07/2002
3	SteroidsIBA 02/2024 - 07/2015
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 11/2022 - 01/2019
3	alpha-SynucleinIBA 08/2015 - 07/2011
3	EnzymesIBA 07/2015 - 12/2009
3	Amantadine (Aman)FDA LinkGeneric 01/2014 - 09/2010
3	Donepezil (Aricept)FDA LinkGeneric 07/2008 - 07/2002
3	Dopamine Agonists (Dopamine Agonist)IBA 07/2008 - 07/2003
2	InterferonsIBA 02/2023 - 01/2021
2	teriflunomideIBA 02/2023 - 01/2019
2	Cladribine FDA LinkGeneric 12/2022 - 01/2022
2	perampanelIBA 07/2022 - 05/2010
2	VaccinesIBA 05/2022 - 02/2022
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 01/2014
2	Alemtuzumab (Campath)FDA Link 04/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 02/2020 - 01/2018
2	LipidsIBA 01/2019 - 11/2011
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2016 - 07/2008
2	Olanzapine (Zyprexa)FDA Link 03/2016 - 01/2011
2	Clozapine (Clozaril)FDA LinkGeneric 03/2016 - 12/2007
2	SynucleinsIBA 08/2015 - 07/2011
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 08/2012
2	agomelatine (S20098)IBA 01/2013 - 08/2012
2	safinamideIBA 01/2012 - 07/2008
2	Vitamin E FDA LinkGeneric 07/2008 - 07/2002
2	Rivastigmine (Exelon)FDA LinkGeneric 05/2007 - 04/2006
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2024
1	Prednisone (Sone)FDA LinkGeneric 02/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2024
1	Hallucinogens (Psychedelics)IBA 12/2023
1	Glatiramer Acetate (Copaxone)FDA Link 02/2023
1	AntigensIBA 01/2023
1	ocrelizumabIBA 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 05/2022
1	Vitamin K FDA Link 05/2022

Therapy/Procedure

20	Therapeutics 12/2023 - 07/2003
4	Immunotherapy 11/2023 - 01/2019
1	Electrodes (Electrode) 01/2023
1	Withholding Treatment 12/2022